Currently out of the existing stock ratings of Per Ostlund, 15 are a BUY (88.24%), 2 are a HOLD (11.76%).

Per Ostlund

Work Performance Price Targets & Ratings Chart

Analyst Per Ostlund, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 61.11% that have a potential upside of 37.83% achieved within 123 days.

Per Ostlund’s has documented 36 price targets and ratings displayed on 6 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on NTRA, Natera at 12-Jan-2025.

Wall Street Analyst Per Ostlund

Analyst best performing recommendations are on NTRA (NATERA).
The best stock recommendation documented was for NTRA (NATERA) at 11/13/2024. The price target of $157 was fulfilled within 1 day with a profit of $3.97 (2.47%) receiving and performance score of 24.66.

Average potential price target upside

CEMI Chembio Diagnostics CDNA Caredx EXAS EXACT Sciences ICAD icad inc NTRA Natera CE Celanese

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Jul-2021

$7.5

5 years 4 days ago
(22-Jul-2021)

2/2 (100%)

$2.76 (58.23%)

256

Hold Since 03-Dec-2020

$10

$9.54 (2073.91%)

$8

5 years 7 months 23 days ago
(03-Dec-2020)

0/3 (0%)

$2.49 (33.16%)

Hold Since 17-Jun-2020

$7

6 years 1 months 9 days ago
(17-Jun-2020)

2/2 (100%)

$-0.16 (-2.23%)

151

Buy Since 26-May-2020

$4

$3.54 (769.57%)

$21

6 years 1 months 9 days ago
(17-Jun-2020)

1/2 (50%)

$0.11 (2.83%)

15

Buy Since 04-Jan-2019

$9

6 years 7 months 10 days ago
(16-Dec-2019)

2/2 (100%)

$4.61 (105.01%)

309

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Per Ostlund?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?